May 19, 2020

NIH begins clinical trial of hydroxychloroquine, azithromycin for COVID-19 treatment

By: Judy Mathias
Tags:
Share

Editor's Note

The National Institutes of Health (NIH) on May 14 announced that it is enrolling adults with mild to moderate COVID-19 in a study of treatment with hydroxychloroquine and azithromycin.

The Phase 2b trial is enrolling around 2,000 adults across the US. Participants must have confirmed infection with SARS-CoV-2 and be experiencing fever, cough, and/or shortness of breath.


Sponsored Message

The participants will be randomly assigned to short-term treatment with either hydroxychloroquine and azithromycin or matching placebos.

Read More >>

Sign Up For OR a.m.
Sign up for the free OR a.m. eLetter to get news like this in your inbox every morning!

OR Manager Jobs
Live chat by BoldChat